Impact of Air Pollution on Chronic Respiratory Diseases
NCT ID: NCT03813810
Last Updated: 2019-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
360 participants
OBSERVATIONAL
2019-01-25
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Accordingly, the investigators have designed an prospective cohort with enrollment of normal people and patients with chronic respiratory diseases of three different categories (chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis). Participants will be followed up for a period of one year, with evaluation of the clinical course of the respiratory disease and exposure to air pollution.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Particulate Matter on the Pulmonary Function and Acute Exacerbation of COPD and Asthma
NCT03193879
the Effects of Air Pollution on Respiratory Diseases in Children
NCT05483881
Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study
NCT04922697
Effect of Atmospheric Pollution on Obstructive Lung Diseases
NCT03059459
Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes
NCT02411240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal
People without any chronic pulmonary diseases.
Non
There would be no interventions. Only measurements will be performed.
Chronic obstructive pulmonary disease
Patients with chronic obstructive pulmonary disease.
Non
There would be no interventions. Only measurements will be performed.
Asthma
Patients with asthma
Non
There would be no interventions. Only measurements will be performed.
Idiopathic pulmonary fibrosis
Patients with idiopathic pulmonary fibrosis
Non
There would be no interventions. Only measurements will be performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non
There would be no interventions. Only measurements will be performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic obstructive pulmonary disease: Patients with over 10 pack-years of smoking history and post bronchodilator FEV1/FVC \<0.7 and FEV1 \< 80%, and no other reason for decline of lung function.
* Asthma: Patients with FEV1/FVC \< 0.85 and increase in over 12% and 200mL of FEV1 by bronchodilator inhalation. Patients with P20 \< 16mg/dL by bronchial provocation test.
* Idiopathic pulmonary fibrosis: Shows usual interstitial pneumonia according to chest CT and has no other reasons such as systematic diseases or medication history.
Exclusion Criteria
* Subjects who experienced an acute exacerbation within 1 month.
* Subjects under age of 19.
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
SMG-SNU Boramae Medical Center
OTHER
National Medical Center, Seoul
OTHER
KangWon National University Hospital
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Air_pollution_cohort
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.